OCUL
Ocular Therapeutix, Inc. · Healthcare
Chief Medical Officer Rabia Gurses Ozden sold $27K of Ocular Therapeutix, Inc.
Sold$27,204
$4.24Price
6,416Shares
−6%Stake
What OCUL did after the filing
- The stock from Wed, Feb 8 close, $4.10
- +20.0%
- S&P 500, same days
- −3.9%
Measured over 30 trading days, to the Mar 23 close.
Traded Mon, Feb 6. Filed Wed, Feb 8, 2:33 PM ET, during the session. Returns use the Feb 8 close and the Mar 23 close. Not investment advice.